Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Europe EU Austria

EU’s Eighth IVDR Notified Body Is Based In Austria

  • News

Executive Summary

The first medtech notified body to be designated in Austria has been listed under the IVDR.

You may also be interested in...



German Notified Body Latest To Be Designated Under MDR

The latest notified body to be listed under the EU Medical Device Regulation brings the total number to 37.

Moves For Go Ahead For MDR Proposal To Be Discussed At European Parliament

The European Commission’s proposal to extend transition timelines for legacy devices in the context of the Medical Device Regulation is already on the move. There are still questions, however, about whether a fast-track adoption is in the best interests of the medtech sector.

Notified Bodies Follow Expert Panel Opinions Under EU MDR To The Letter

A review of expert panel opinions related to high-risk medical devices shows no challenges yet by notified bodies to their findings.

Table

View full table

Topics

Tags:
Europe EU Austria
Latest Headlines

Philips Implements Plan To Address FDA Concerns Following Harsh Inspection Report

News We're Watching – 27 January

Product Liability Missteps Top List Of Worst Legal Verdicts Of 2022

EMA Expert Advice Pilot Could Be ‘Vital Source Of Guidance’ For SMEs

See All
UsernamePublicRestriction

Register

MT147483

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By